AXSM — Axsome Therapeutics Inc
In 2026 Q2, 9 of the 140 tracked hedge funds reported a position in Axsome Therapeutics Inc (AXSM), worth $131.94M combined. Over the quarter 5 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $64.13M | 0.09% | +59.5% |
| Emerald | $25.51M | 0.60% | -3.1% |
| Emerald Mutual | $16.45M | 0.58% | +0.2% |
| Panoramic | $10.77M | 4.60% | NEW |
| VanEck | $7.17M | 0.00% | -22.2% |
| Essex | $3.98M | 0.52% | -0.5% |
| IMC | $2.49M | 0.02% | +29.8% |
| Caxton Associates | $1.05M | 0.02% | -0.5% |
| Persistent | $385.02K | 0.12% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.